Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009–2013

ABSTRACT This study documented the number and results of mycobacterial culture and drug sensitivity testing (CDST) in Mexico from 2009–2013 and assessed whether states with a higher risk of multidrug-resistant tuberculosis (MDR-TB) performed more CDST and had more cultures showing MDR-TB. Data for t...

Full description

Bibliographic Details
Main Authors: Ivonne Orejel, Martin Castellanos, Diana Marín, Alberto Mendoza, Anthony D. Harries
Format: Article
Language:English
Published: Pan American Health Organization
Series:Revista Panamericana de Salud Pública
Subjects:
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892016000100065&lng=en&tlng=en
id doaj-96fe335649104148b70e817bcfd5294d
record_format Article
spelling doaj-96fe335649104148b70e817bcfd5294d2020-11-25T00:03:02ZengPan American Health OrganizationRevista Panamericana de Salud Pública1680-53483916568S1020-49892016000100065Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009–2013Ivonne OrejelMartin CastellanosDiana MarínAlberto MendozaAnthony D. HarriesABSTRACT This study documented the number and results of mycobacterial culture and drug sensitivity testing (CDST) in Mexico from 2009–2013 and assessed whether states with a higher risk of multidrug-resistant tuberculosis (MDR-TB) performed more CDST and had more cultures showing MDR-TB. Data for this longitudinal, descriptive, operational research study came from the electronic records of 31 state public health laboratories in Mexico. The total number of CDSTs was 6 470, increasing from 2 143 in the first 2 years to 4 327 in the latter 3 years. There was a significant increase in the proportion of cultures showing sensitivity to all drugs, from 53.1% to 60.9% in 2011–2013 (P < 0.001) and a significant decrease in the proportion showing MDR-TB, from 28.2% in 2009 to 19.8% in 2013 (P < 0.001). Cases of extensively drug resistant tuberculosis were < 1% per year. In the 12 states with higher risk for MDR-TB, significantly more CDSTs (2 382 test) were done in 2011–2013 than in the other 19 states (1 945 tests). Also, for each year the proportion of cultures showing MDR-TB was significantly higher in high risk MDR-TB states than in lower risk ones (P < 0.001). During the 5-year study period, CDST was scaled up in Mexico, particularly in high-risk MDR-TB states where a higher proportion of cultures showed MDR-TB. Scale up and wider coverage of CDST should continue.http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892016000100065&lng=en&tlng=enTuberculosistécnicas de cultivopruebas de sensibilidad microbianatuberculosis resistente a múltiples medicamentostuberculosis extensivamente resistente a drogasinvestigación operativaMéxico
collection DOAJ
language English
format Article
sources DOAJ
author Ivonne Orejel
Martin Castellanos
Diana Marín
Alberto Mendoza
Anthony D. Harries
spellingShingle Ivonne Orejel
Martin Castellanos
Diana Marín
Alberto Mendoza
Anthony D. Harries
Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009–2013
Revista Panamericana de Salud Pública
Tuberculosis
técnicas de cultivo
pruebas de sensibilidad microbiana
tuberculosis resistente a múltiples medicamentos
tuberculosis extensivamente resistente a drogas
investigación operativa
México
author_facet Ivonne Orejel
Martin Castellanos
Diana Marín
Alberto Mendoza
Anthony D. Harries
author_sort Ivonne Orejel
title Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009–2013
title_short Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009–2013
title_full Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009–2013
title_fullStr Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009–2013
title_full_unstemmed Culture and drug sensitivity testing among patients with pulmonary tuberculosis in Mexico: national data for 2009–2013
title_sort culture and drug sensitivity testing among patients with pulmonary tuberculosis in mexico: national data for 2009–2013
publisher Pan American Health Organization
series Revista Panamericana de Salud Pública
issn 1680-5348
description ABSTRACT This study documented the number and results of mycobacterial culture and drug sensitivity testing (CDST) in Mexico from 2009–2013 and assessed whether states with a higher risk of multidrug-resistant tuberculosis (MDR-TB) performed more CDST and had more cultures showing MDR-TB. Data for this longitudinal, descriptive, operational research study came from the electronic records of 31 state public health laboratories in Mexico. The total number of CDSTs was 6 470, increasing from 2 143 in the first 2 years to 4 327 in the latter 3 years. There was a significant increase in the proportion of cultures showing sensitivity to all drugs, from 53.1% to 60.9% in 2011–2013 (P < 0.001) and a significant decrease in the proportion showing MDR-TB, from 28.2% in 2009 to 19.8% in 2013 (P < 0.001). Cases of extensively drug resistant tuberculosis were < 1% per year. In the 12 states with higher risk for MDR-TB, significantly more CDSTs (2 382 test) were done in 2011–2013 than in the other 19 states (1 945 tests). Also, for each year the proportion of cultures showing MDR-TB was significantly higher in high risk MDR-TB states than in lower risk ones (P < 0.001). During the 5-year study period, CDST was scaled up in Mexico, particularly in high-risk MDR-TB states where a higher proportion of cultures showed MDR-TB. Scale up and wider coverage of CDST should continue.
topic Tuberculosis
técnicas de cultivo
pruebas de sensibilidad microbiana
tuberculosis resistente a múltiples medicamentos
tuberculosis extensivamente resistente a drogas
investigación operativa
México
url http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892016000100065&lng=en&tlng=en
work_keys_str_mv AT ivonneorejel cultureanddrugsensitivitytestingamongpatientswithpulmonarytuberculosisinmexiconationaldatafor20092013
AT martincastellanos cultureanddrugsensitivitytestingamongpatientswithpulmonarytuberculosisinmexiconationaldatafor20092013
AT dianamarin cultureanddrugsensitivitytestingamongpatientswithpulmonarytuberculosisinmexiconationaldatafor20092013
AT albertomendoza cultureanddrugsensitivitytestingamongpatientswithpulmonarytuberculosisinmexiconationaldatafor20092013
AT anthonydharries cultureanddrugsensitivitytestingamongpatientswithpulmonarytuberculosisinmexiconationaldatafor20092013
_version_ 1725435425725612032